Celularity (CELU) Operating Leases (2022 - 2025)
Celularity's (CELU) quarterly Operating Leases came in at $26.9 million in Q4 2025, up 1.32% year-over-year from $26.5 million in Q4 2024, and little changed quarter-over-quarter from $26.8 million in Q3 2025.
Analysis
Celularity (CELU) Operating Leases (2022 - 2025) Analysis & Trends
Celularity (CELU) has reported Operating Leases for 4 consecutive years, with $26.9 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Operating Leases rose 1.32% year-over-year to $26.9 million in Q4 2025; TTM through Dec 2025 was $26.9 million, a 1.32% increase from a year earlier, with the FY2025 full-year figure at $26.9 million, up 1.32% from the prior year.
- Operating Leases was $26.9 million for Q4 2025 at Celularity, roughly flat from $26.8 million in the prior quarter.
- Over five years, Operating Leases peaked at $30.5 million in Q1 2022 and troughed at $26.1 million in Q3 2023.
- A 4-year average of $27.2 million and a median of $26.8 million in 2025 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases decreased 7.92% in 2023 and gained 1.45% in 2024, its largest moves.
- Over 4 years, Operating Leases stood at $28.0 million in 2022, then declined by 6.46% to $26.2 million in 2023, then rose by 1.42% to $26.5 million in 2024, then increased by 1.32% to $26.9 million in 2025.
- The last three Operating Leases figures came in at $26.9 million (Q4 2025), $26.8 million (Q3 2025), and $26.7 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Celularity | 36.35 Mn | 30.17 Mn | -3.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 26.90 Mn |
| Sep 30, 2025 | 26.81 Mn |
| Jun 30, 2025 | 26.72 Mn |
| Mar 31, 2025 | 26.63 Mn |
| Dec 31, 2024 | 26.55 Mn |
| Sep 30, 2024 | 26.45 Mn |
| Jun 30, 2024 | 26.36 Mn |
| Mar 31, 2024 | 26.27 Mn |
| Dec 31, 2023 | 26.18 Mn |
| Sep 30, 2023 | 26.07 Mn |
| Jun 30, 2023 | 28.10 Mn |
| Mar 31, 2023 | 28.05 Mn |
| Dec 31, 2022 | 27.99 Mn |
| Sep 30, 2022 | 27.92 Mn |
| Jun 30, 2022 | 27.85 Mn |
| Mar 31, 2022 | 30.46 Mn |